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Infections with Schmallenberg virus (SBV) are asso-
ciated with congenital malformations in ruminants. Because 
reporting of suspected cases only could underestimate the 
true rate of infection, we conducted a seroprevalence study 
in the Netherlands to detect past exposure to SBV among 
dairy cattle. A total of 1,123 serum samples collected from 
cattle during November 2011–January 2012 were tested 
for antibodies against SBV by using a virus neutralization 
test; seroprevalence was 72.5%. Seroprevalence was 
signifi cantly higher in the central-eastern part of the 
Netherlands than in the northern and southern regions 
(p<0.001). In addition, high (70%–100%) within-herd 
seroprevalence was observed in 2 SBV-infected dairy herds 
and 2 SBV-infected sheep herds. No signifi cant differences 
were found in age-specifi c prevalence of antibodies against 
SBV, which is an indication that SBV is newly arrived in the 
country.
During the last 2 weeks of August and the fi rst 2 weeks of September 2011, dozens of veterinary practitioners 
in the Netherlands reported to a monitoring help desk (GD 
Veekijker) that several dairy herds with cows showed a 
sudden decrease in milk production, watery diarrhea, and 
occasional fever (1). The affected animals recovered, and 
extensive bacteriologic, virologic, and parasitologic testing 
of feces and blood samples of sick cows did not reveal an 
infectious cause for the clinical signs. Similar problems 
were reported at about the same time in Germany, and 
on November 18, 2011, the Friedrich Loeffl er Institute 
(Greifswald, Germany) reported the detection of a novel 
orthobunyavirus that could be the cause of the clinical 
problems (2). Real-time reverse transcription PCR (RT-
PCR), made available by the Friedrich Loeffl er Institute, 
was used to test stored blood samples (N = 50) from the 
clinically diseased cattle in the Netherlands; 36% had 
positive test results. Since then, the virus has also been 
associated with congenital malformations in young animals 
(lambs, goat kids, and calves) (3).
The new virus is provisionally called Schmallenberg 
virus (SBV), or Shamonda-like virus. It is a RNA virus and 
shows 97% identity with Shamonda virus (SHAV) (small 
gene segment), 71% identity with Aino virus (medium 
gene segment), and 69% identity with Akabane virus 
(AKAV) (large gene segment) (4). All these viruses are 
part of the Simbu serogroup of the family Bunyaviridae, 
genus Orthobunyavirus. The Simbu serogroup is composed 
of several arthropod-borne viruses (arboviruses, including 
SHAV, AKAV, and Aino virus) transmitted by Culicoides 
spp. biting midges and mosquitos. SHAV was initially 
isolated from cattle and Culicoides spp. biting midges in 
Nigeria in the 1960s (5,6). In 2002, SHAV emerged in 
Japan and was isolated from Culicoides spp. biting midges 
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and sentinel cattle (7). Japan has been considered an area to 
which several Simbu group viruses have been endemic in 
cattle since the 1970s (8).
Knowledge specifi cally related to SBV is limited; 
according to a risk assessment by the European Centre for 
Disease Prevention (http://ecdc.europa.eu/en/publications/
Pub l i ca t ions /231112_TER_Risk_assessement_
Schmallenberg_virus.pdf), transmission of SBV to humans 
is considered unlikely but cannot be ruled out. Recently, 
serosurveys were conducted to assess zoonotic transmission 
of SBV in farmers and veterinarians in Germany and the 
Netherlands, who are likely to come in contact with the 
virus, but no infection was found (9,10).
In the Netherlands, reporting of suspected cases of 
SBV infection in animals (occurrence of arthrogryposis 
hydranencephaly syndrome in calves, lambs, and goat kids) 
is obligatory; a report is followed by confi rmatory testing 
of brain tissue samples by RT-PCR. However, the observed 
suspected cases are likely an underestimation of the true rate 
of infection; in addition, infected livestock may give birth 
to healthy young animals, adding to the underestimation of 
the true rate of infection. Therefore, serodiagnostic studies 
are needed to detect past exposure to SBV in ruminant 
populations in the affected countries. Within weeks after 
the start of the SBV epidemic, a virus neutralization test 
(VNT) was developed at the Central Veterinary Institute 
(CVI). This test made it possible to quickly execute a 
seroprevalence study of antibodies against SBV in dairy 
cattle in the Netherlands.
Materials and Methods
Seroprevalence Sampling Design
To estimate the seroprevalence of SBV in the dairy 
cattle population in the Netherlands with considerable 
precision, we used the following preconditions for sample 
size calculation (11): an a priori expected prevalence of 
50% (this will yield the highest possible sample size), a 
maximum allowable error in the prevalence estimate of 
≈3%, a 95% confi dence in the estimate, and a population 
size of ≈1.5 million head of dairy cattle (on the basis of 
2012 census data of Statistics Netherlands, The Hague, the 
Netherlands). These conditions yielded a calculated sample 
size of >1,100 randomly selected dairy cattle.
Because dairy cattle and the premises on which 
they are housed are not distributed homogenously in the 
Netherlands, a stratifi ed random sampling design with the 
12 provinces in the Netherlands as a stratifi cation level was 
set up to provide a representative sample. On the basis of 
census data of Statistics Netherlands (12), the stratifi ed 
distribution of dairy cattle by province was used for setting 
up the sampling frame. The sampling frame comprised 
dairy cattle from which serum samples were collected 
during November 2011–January 2012 for monitoring 
testing of antibodies against bluetongue virus or as part of 
a specifi c surveillance investigation of 125 dairy farms to 
exclude introduction of notifi able animal diseases because 
of purchase of possibly contaminated bedding material 
from a third country. Serum samples from these dairy cattle 
were stored at CVI and were available for our study. The 
dairy cattle in our fi nal sampling list (most drawn from the 
bluetongue monitoring set, completed with 37 randomly 
selected samples originating from 12 cattle herds from 
the surveillance investigation set) were randomly selected 
within each stratum (province) of the sampling frame 
proportional to the number of dairy cattle in each province. 
This process provided an accurate representation of dairy 
cattle of the target population in our sample.
Animals within a herd share common characteristics 
such as nutrition, housing, and exposure to disease 
pathogens (13). In the case of infectious diseases, common 
exposure to disease pathogens probably results in a 
common serologic status within herds. As a consequence, 
differences in prevalence between herds are larger than 
differences between animals within herds. Therefore, it is 
essential to sample relatively more herds and fewer animals 
within a herd than in a situation without clustering of 
disease events, as was shown for estimating the population 
prevalence for pseudorabies virus infection (14). A measure 
for agreement in serologic status between animals within a 
herd is given by the intraclass correlation coeffi cient μ (15). 
Because we presumed a high intraclass correlation with 
respect to serologic status of animals within herds (based 
on preliminary test results from a few infected herds), on 
average 2 dairy cattle (minimum 1, maximum 4) from 
the same dairy herd were included in the sampling list to 
prevent occurrence of too many cattle from the same herd. 
This selection procedure resulted in 1,123 samples from 
dairy cattle from 489 dairy herds.
In addition to estimating seroprevalence of SBV in the 
dairy cattle population in the Netherlands, we estimated the 
seroprevalence in the dairy cattle population by 3 regions in 
the Netherlands to determine possible regional differences 
in seroprevalence. These regions were the northern part 
of the Netherlands (465 samples), comprising Groningen, 
Friesland, Drenthe, and Noord-Holland Provinces; the 
southern part of the Netherlands (196 samples), comprising 
Zeeland, Zuid-Holland, Noord-Brabant, and Limburg 
Provinces; and the central-eastern part of the Netherlands 
(462 samples), comprising Overijssel, Gelderland, 
Flevoland, and Utrecht Provinces. A cattle density map on 
municipality level was created on the basis of the number 
of cattle per municipality as received from the “Dienst 
Regelingen” from the Ministry of Economic Affairs, 
Agriculture and Innovation. Figure 1 shows the geographic 
distribution of dairy herds from which we tested, on 
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average, 2 dairy cattle. The data indicate that our sampling 
was indeed representative for the geographic distribution of 
cattle in the Netherlands.
The mean age of cattle tested was 23 months (range 
12–79 months); 60% were 20–24 months of age. To test 
possible differences in age-specifi c antibody prevalence for 
cattle in the northern, central-eastern, and southern regions, 
we defi ned 3 age cohorts: <18 months, 18–24 months, and 
>24 months. Date of birth and date of blood sampling were 
available for 1,085 head of cattle, which enabled us to 
calculate the age of the cattle at the date of blood sampling.
Within-herd Seroprevalence
To gain insight into the within-herd seroprevalence of 
infected herds (based on RT-PCR test results of malformed 
lambs and calves that had been born), we sampled 2 cattle 
herds and 2 sheep fl ocks for comparison. We used the 
following preconditions for sample size calculation: an a 
priori expected prevalence of ≈70%, a maximum allowable 
error in the prevalence estimate of ≈5%, and a 95% 
confi dence in the estimate.
Sheep fl ock 1 consisted of 800 ewes >1 year of age, 
120 ewes <1 year of age, and 14 rams. The fl ock was 
located in the eastern part of the Netherlands. From the 
beginning of the study through December 30, 2011, a total 
of 41 lambs were born; 15 lambs (37%) were malformed. 
Clinical signs observed in the malformed lambs were 
arthrogryposis, ankylosis, scoliosis, torticollis, kyfosis, and 
hydranencephaly. From this fl ock, 60 ewes that had already 
lambed were tested.
Sheep fl ock 2 consisted of 81 ewes >1 year of age and 
1 male ram. The fl ock was located in the southern part of 
the Netherlands. From the beginning of the study through 
February 7, 2012, a total of 30 lambs were born (15 female 
and 15 male); 2 lambs (13%) were malformed (1 female 
and 1 male). Clinical signs observed in the malformed 
lambs were arthrogryposis, ankylosis, torticollis, ataxia, 
and neurologic signs. From this fl ock, 35 ewes that had 
already lambed were tested.
Dairy herd 1 consisted of 58 dairy cattle >2 years of 
age and 40 young stock <2 years of age. The fl ock was 
located in the southwestern part of the Netherlands. From 
the beginning of the study through February 8, 2012, 1 
calf was born malformed. Clinical signs observed in the 
malformed calf were arthrogryposis and ankylosis. From 
this herd, 34 dairy cattle were tested.
Dairy herd 2 consisted of 40 dairy cattle >2 years of age 
and 20 young stock <2 years of age. The fl ock was located 
in the northern part of the Netherlands. From the beginning 
of the study through January 30, 2012, 2 malformed calves 
(twins) were born. Clinical signs observed in the malformed 
calves were scoliosis and hydranencephaly. From this herd, 
34 dairy cattle were tested.
Statistical Analysis
Exact 95% CIs for estimated seroprevalences were 
calculated according to Fleiss (16). Differences in mean 
seroprevalence of antibodies against SBV of dairy cattle 
populations between regions in the Netherlands were tested 
with the 2-sample proportion test (17). Differences in age-
specifi c mean prevalence of antibodies against SBV of 
dairy cattle in the northern, southern, and central-eastern 
region were tested with the 2-sample proportion test (17).
An intraclass correlation coeffi cient μ was calculated 
to measure the agreement in serologic status between 
dairy cattle sampled within the same herd. The intraclass 
correlation coeffi cient (minimum 0, maximum 1) was 
estimated by using analysis of variance, with herd as 
independent variable and the serologic status of individual 
animals (seropositive or seronegative) as dependent 
variable (15).
Serologic Test
Serum samples were tested in a VNT against SBV 
(W.L.A. Loeffen et al., unpub. data). A virus isolate from 
brain tissue of a lamb, fourth passage on Vero (African 
green monkey kidney) cells, was used in the test, which 
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Figure 1. Geographic distribution of dairy herds from which 1–4 
animals were sampled (red dots) in study of Schmallenberg virus 
seroprevalence, the Netherlands, 2011–2012. Cattle density is 
indicated by gray shading; blue outlines denote regional borders.
RESEARCH
was performed in fl at-bottomed, 96-well microtiter plates 
on VERO cells. The medium used for cells and dilutions 
was Dulbecco minimal essential medium + Glutamax 
(GIBCO Invitrogen, Carlsbad, CA, USA), contained with 
3% fetal calf serum and 1% penicillin and streptomycin at 
fi nal concentrations of 100 IU and 100 μg/mL, respectively, 
in the medium. Serum samples were heated for 30 min at 
56°C before testing. Serum samples were diluted in the 
test plate, starting from 1:4, followed by 2-fold dilutions 
up to 1:512 in volumes of 50 μL. Subsequently, virus (500 
median tissue culture infective dose per well) was added to 
each well, also in a volume of 50 μL. After preincubation 
at 37°C for 1–2 hours, 20,000 cells per well were added in 
a volume of 100 μL. Plates were incubated for 5 days at 
37°C in 5% CO2.
After 5 days, the plates were emptied and stained with 
amido black. The titer was determined as the reciprocal of 
the dilution in which 25%–100% of the monolayer was 
still intact. Titers >8 were considered positive on the basis 
of a prior validation in which a specifi city and sensitivity 
of >99% were estimated with this cutoff. Control samples 
(positives and negatives) were included in each run of the 
test. Virus used in each run was back titrated in 24 columns 
of 4 dilutions each.
Results
The estimated seroprevalence of antibodies against 
SBV in dairy cattle, winter 2011–2012, for the Netherlands 
(N = 1,123) was 72.5% (95% CI 69.7%–75.1%). The 
agreement in serologic status between dairy cattle sampled 
within the same herd in our prevalence study, as measured 
by the intraclass correlation coeffi cient, was high, 0.73. 
This fi nding indicates that in any particular herd, a strong 
tendency exists that either most cattle in that herd will be 
seropositive or most will be seronegative.
We found no statistically signifi cant (p>0.05) 
differences in age-specifi c mean prevalence of antibodies 
against SBV of cattle in the 3 regions (Table). In the 
southern and northern regions, we found a slight trend of 
increased seroprevalence from the younger to the older age 
cohorts; in the central-eastern region, this trend was absent.
Figure 2 shows the geographic distribution of 
seropositive dairy herds (>1 cows sampled tested 
seropositive) and seronegative dairy herds (all cows 
sampled tested seronegative). These data indicate no 
association between cattle density and occurrence of 
seropositive or seronegative herds. Furthermore, the 
geographic distribution of seropositive and seronegative 
herds is random, showing no specifi c clusters of seropositive 
or seronegative herds. The estimated seroprevalence of 
antibodies against SBV in dairy cattle in the central-eastern 
part of the Netherlands (n = 462; seroprevalence 82.7%, 
95% CI 78.8%–86.0%) was signifi cantly (p<0.001) higher 
than the estimated seroprevalence of antibodies against 
SBV in dairy cattle in the northern (n = 465; seroprevalence 
67.1%, 95% CI 62.6%–71.3%) and southern (n = 196; 
seroprevalence 61.2%, 95% CI 53.9%–68.0%) parts of the 
country. Figure 3 shows the distribution of VNT antibody 
titers against SBV of seropositive samples from dairy 
cattle; 50% of the samples showed a titer >512.
For testing of within-herd seroprevalence, in dairy 
herd 1, 25/34 cows tested seropositive (within-herd 
seroprevalence 73.5%, 95% CI 55%–87%); in dairy herd 2, 
all 34 cows tested seropositive (within-herd seroprevalence 
100%, 95% CI 87%–100%). In sheep fl ock 1, 56/60 ewes 
tested seropositive (within-fl ock seroprevalence 93.3%, 
95% CI 82%–98%); in sheep fl ock 2, 25/35 ewes tested 
seropositive (within-fl ock seroprevalence 71.4%, 95% CI 
52%–85%). 
Discussion
We found a high seroprevalence of antibodies against 
SBV in dairy cattle in the Netherlands in the winter of 
2011–2012, which indicates widespread exposure to SBV 
during the biting insect seasons of spring, summer, and 
fall 2011. Between the start of the investigation and last 
day of the surveillance period (March 29, 2012), a total of 
782 calves with suspected SBV infection were tested by 
PCR in the Netherlands (Netherlands Food and Consumer 
Product Safety Authority, www.vwa.nl/onderwerpen/
dierziekten/dossier/schmallenbergvirus); only 14% had 
positive test results. Combined with our study results 
on within-herd seroprevalence and the fact that a certain 
population of infected livestock would not produce 
malformed calves because the dams were infected outside 
the critical period of pregnancy, this fi nding illustrates the 
considerable underestimation of the true rate of infection in 
the population when only counting suspected cases.
The seroprevalence of antibodies against SBV in dairy 
cattle is signifi cantly higher in the central-eastern part of 
the Netherlands than in the northern and southern parts of 
the country. This fi nding likely indicates that SBV was fi rst 
introduced into the eastern part of the Netherlands and is 
supported by the fact that the fi rst dairy herds reporting 
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Table. Age-specific mean prevalence of antibodies against Schmallenberg virus among cattle, the Netherlands, 2011–2012 
Age range, mo 
No. cattle (prevalence, %) 
Northern region Central-eastern region Southern region Total 
<18 7 (42.9) 13 (76.9) 13 (46.2) 33 (57.6) 
18–24 331 (65.0) 337 (82.8) 151 (60.9) 819 (71.6) 
>24 103 (72.8) 98 (80.6) 32 (68.8) 233 (75.5) 
Schmallenberg Virus and Dairy Cattle, the Netherlands
cows with clinical signs of SBV infection in September 
2011 were located in the same areas (1).
We found no signifi cant differences in age-specifi c 
mean prevalence of antibodies against SBV of cattle in the 
3 regions, which indicates that SBV is newly arrived in 
the area. A clear increasing age-specifi c prevalence would 
have suggested that the virus had been there for 2–3 years 
but unrecognized earlier on. In the southern and northern 
region, there was a slight trend of increased seroprevalence 
from the young to the older age-cohorts, which can be 
expected because the young age cohort is housed inside for 
most of the time, preventing exposure to infected vectors. 
In the central-eastern region, this trend was absent, which 
is another indication that SBV was fi rst introduced into the 
eastern part of the Netherlands.
Testing of serum samples banked during other studies 
before 2011 is planned to determine whether evidence 
exists of SBV infection before 2011. We could fi nd no 
comparable seroprevalence studies on SBV or SHAV 
activity from other countries. However, a seroprevalence 
study conducted at the end of the New South Wales AKAV 
epidemic that occurred during April–October 1974 showed 
80% seroprevalence in ≈4,000 serum samples from cattle 
(18). This fi nding illustrates that an outbreak season with 
another orthobunyavirus can result in a comparable level 
of infection to that found in our study.
Regarding SBV within-herd seroprevalence, our 
preliminary results indicate that, by the end of an outbreak 
season, most animals within an affected herd have been 
infected. Previous studies investigating AKAV outbreaks 
showed comparably high within-herd seroprevalence of 
antibodies in cattle in Australia: 77% in 1964 (19), up to 89% 
in 1971 (20), and 99% in 1988 in New South Wales (21). 
Furthermore, serologic investigations in the Kumamoto 
and Kagoshima Prefectures in Japan, where 98.3% of 119 
tested cattle with neurologic signs were seropositive against 
AKAV, showed that 74.3% of cohabitated cattle without 
neurologic signs in these farms were also seropositive (22). 
Monthly sampling of sentinel cattle in Australia indicated 
that within 1–2 months after the start of sampling, 100% 
of the sentinel animals within herds were seropositive for 
AKAV exposure (23,24).
We cannot predict the progress of SBV during 
the coming months in the ruminant populations in the 
Netherlands. While a certain level of protection against 
new infection may be expected for naturally infected 
animals, but to our knowledge, no solid information on the 
protective capacity of SBV antibodies exists. In addition, 
in a population showing a seroprevalence of 70%, it should 
be assumed that a considerable portion of animals remain 
susceptible to SBV infection. Recent reports of SBV in 
Culicoides spp. biting midges from Belgium and Denmark 
implicated C. obsoletus complex and C. dewulfi  midges as 
potential vectors in the transmission and spread of SBV 
(25,26). From experiences with other ruminant Simbu 
serogroup viruses in Asia and Australia, it may be assumed 
that, if previously uninfected animals are infected by 
vectors before mating, protection would be incurred against 
the occurrence of congenital malformations in newborns 
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Figure 2. Geographic distribution of dairy herds sampled in study 
of Schmallenberg virus seroprevalence with positive results (>1 
animals sampled tested seropositive; red dots) and negative 
results (all animals sampled tested seronegative; yellow dots), 
the Netherlands, 2011–2012. Cattle density is indicated by gray 
shading; blue outlines denote regional borders.
Figure 3. Frequency distribution of titers for serum samples (n = 814) 
positive for Schmallenberg virus antibodies by virus neutralization 
test (VNT) in study of Schmallenberg virus seroprevalence, the 
Netherlands, 2011–2012.
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(27). Vaccination of the dams before they are mated would 
likely produce a similar protection; however, no vaccine 
for SBV is available. 
Our study estimated seroprevalence at the population 
level and showed differences in seroprevalence among 
regions within the Netherlands. If an estimate of 
seroprevalence is desired at a more detailed regional level, 
a larger number of animals must be sampled and tested. 
This estimate will be feasible (cost- and labor-wise) when 
samples are tested with the VNT using a limited number of 
dilutions or an ELISA (less expensive and labor-intensive 
than the VNT) becomes available.
When designing our prevalence study, we assumed 
a high agreement in serologic status among dairy cattle 
sampled within the same herd. The observed within-herd 
prevalence and the high agreement in serologic status 
among dairy cattle sampled within the same herd in our 
study retrospectively indicate that sampling a relatively low 
number of animals within a herd and relatively more herds 
enables an accurate estimate of the overall seroprevalence 
of the dairy cattle population. These infection dynamic 
characteristics can be used by other research groups when 
designing future seroprevalence studies in the other SBV-
affected countries.
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